Robert Langer Moderna, Inc. (MRNA) insider trading activity

MRNA Quotes by TradingView

Robert Langer is Director of Moderna, Inc.. Currently has a direct ownership of 11.5 Million shares of MRNA, which is worth approximately $494 Million. The most recent transaction as insider was on Apr 28, 2022, when has been sold 703 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 11.5M
0% 3M change
0% 12M change
Total Value Held $494 Million

ROBERT LANGER Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 28 2022
BUY
Exercise of conversion of derivative security
-
703 Added 0.01%
11,467,664 Common Stock
Dec 11 2018
BUY
Conversion of derivative security
-
4,559 Added 0.04%
11,466,961 Common Stock

Also insider at

FREQ
Frequency Therapeutics, Inc. Healthcare
Director
SEER
Seer, Inc. Healthcare
RL

Robert Langer

Director
Cambridge, MA

Track Institutional and Insider Activities on MRNA

Follow Moderna, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MRNA shares.

Notify only if

Insider Trading

Get notified when an Moderna, Inc. insider buys or sells MRNA shares.

Notify only if

News

Receive news related to Moderna, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on MRNA